Ultragenyx Pharmaceutical
Katie Bloom (Feid) is an experienced professional in program management, currently serving as Executive Director of Program Management at Ultragenyx since November 2017. Katie has held multiple leadership positions at Ultragenyx, including Senior Director and Director within the Gene Therapy division, as well as Associate Director. Prior to Ultragenyx, Katie worked at Dimension Therapeutics as Associate Director of Program Management and held various roles at ImmunoGen, Inc. from 2007 to 2016, including CMC Project Manager and Quality Control Manager. Earlier career experience includes positions at Genzyme, Organogenesis, Inc., and an internship at Bayer. Katie holds a degree in Biology with a minor in Chemistry from Hofstra University.
This person is not in any teams
This person is not in any offices
Ultragenyx Pharmaceutical
11 followers
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.